Research programme: IPL4 series - Inflazyme
Alternative Names: Bispan; IPL4 series research programme - InflazymeLatest Information Update: 02 Aug 2004
At a glance
- Originator Inflazyme Pharmaceuticals
- Class
- Mechanism of Action Phosphotransferase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 02 Aug 2004 Discontinued - Preclinical for Rheumatoid arthritis in North America (unspecified route)
- 26 Feb 2003 No development reported - Preclinical for Rheumatoid arthritis in North America (unspecified route)
- 24 Feb 2000 Lead selection for the rheumatoid arthritis indication is underway